Show simple item record

dc.contributor.authorLukin, Izeia
dc.contributor.authorErezuma, Itsasne
dc.contributor.authorMaeso, Lidia
dc.contributor.authorZarate Sesma, Jon ORCID
dc.contributor.authorDesimone, Martin Federico
dc.contributor.authorAlTel, Taleb ORCID
dc.contributor.authorDolatshahi-Pirouz, Alireza ORCID
dc.contributor.authorOrive Arroyo, Gorka
dc.date.accessioned2022-08-03T10:03:14Z
dc.date.available2022-08-03T10:03:14Z
dc.date.issued2022
dc.identifier.citationPharmaceutics 14(6) : (2022) // Article ID 1177es_ES
dc.identifier.issn1999-4923
dc.identifier.urihttp://hdl.handle.net/10810/57174
dc.description.abstractTissue engineering has become a medical alternative in this society with an ever-increasing lifespan. Advances in the areas of technology and biomaterials have facilitated the use of engineered constructs for medical issues. This review discusses on-going concerns and the latest developments in a widely employed biomaterial in the field of tissue engineering: gelatin. Emerging techniques including 3D bioprinting and gelatin functionalization have demonstrated better mimicking of native tissue by reinforcing gelatin-based systems, among others. This breakthrough facilitates, on the one hand, the manufacturing process when it comes to practicality and cost-effectiveness, which plays a key role in the transition towards clinical application. On the other hand, it can be concluded that gelatin could be considered as one of the promising biomaterials in future trends, in which the focus might be on the detection and diagnosis of diseases rather than treatment.es_ES
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Economy, Industry, and Competi- tiveness (PID2019-106094RB-I00/AEI/10.13039/501100011033) and the Basque Government who awarded Ph.D. grants (I.L. PRE_2021_2_0023; I.E. PRE_2021_2_0021).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2019-106094RB-I0es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectgelatines_ES
dc.subjectbiomaterialses_ES
dc.subjectregenerative medicinees_ES
dc.subjecttissue engineeringes_ES
dc.titleProgress in Gelatin as Biomaterial for Tissue Engineeringes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2022-06-23T12:21:40Z
dc.rights.holder© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/14/6/1177es_ES
dc.identifier.doi10.3390/pharmaceutics14061177
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Except where otherwise noted, this item's license is described as © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).